tiprankstipranks
Trending News
More News >
SCYNEXIS Faces Challenges Amidst Antifungal Developments
PremiumCompany AnnouncementsSCYNEXIS Faces Challenges Amidst Antifungal Developments
2M ago
Scynexis reports Q1 EPS (11c), consensus (19c)
Premium
The Fly
Scynexis reports Q1 EPS (11c), consensus (19c)
2M ago
Scynexis expects cash to fund operations into Q3 of 2026
Premium
The Fly
Scynexis expects cash to fund operations into Q3 of 2026
2M ago
Scynexis reports Q3 EPS (6c), consensus (7c)
PremiumThe FlyScynexis reports Q3 EPS (6c), consensus (7c)
8M ago
Is SCYX a Buy, Before Earnings?
Premium
Pre-Earnings
Is SCYX a Buy, Before Earnings?
8M ago
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook
Premium
Company Announcements
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook
10M ago
Scynexis reports FY23 EPS $1.39, consensus $1.42
PremiumThe FlyScynexis reports FY23 EPS $1.39, consensus $1.42
1y ago
SCYX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SCYX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
Scynexis announces presentation of data from fungerp candidate SCY-247
Premium
The Fly
Scynexis announces presentation of data from fungerp candidate SCY-247
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100